Initial results from a first-in-human, phase I study of immunomodulatory aryl hydrocarbon receptor (AhR) inhibitor BAY2416964 in patients with advanced solid tumors
Dumbrava, E. E. Cecchini, M. Zugazagoitia, J. Lopez, J. S. Jäger, D. Oliva, M. Ochsenreither, S. Gambardella, V. Chung, K. Y. Longo, F.
Dumbrava, E. E.
Cecchini, M.
Zugazagoitia, J.
Lopez, J. S.
Jäger, D.
Oliva, M.
Ochsenreither, S.
Gambardella, V.
Chung, K. Y.
Longo, F.
Citations
Altmetric:
Abstract
Description
Date
2023
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Dumbrava EE, Cecchini M, Zugazagoitia J, Lopez JS, Jäger D, Oliva M, et al. Initial results from a first-in-human, phase I study of immunomodulatory aryl hydrocarbon receptor (AhR) inhibitor BAY2416964 in patients with advanced solid tumors. Journal of Clinical Oncology. 2023 Jun;41(16). PubMed PMID: WOS:001053772000404.